KCT0012294Active, not recruitingNot Applicable
A clinical trial to verify the accuracy of MEDIGARD pulse oximeter (WELLCARE100) in healthy volunteers
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Asan Medical Center
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Primary Purpose
- Other(Accuracy evaluation of pulse oximeter), Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
Eligibility Criteria
- Ages
- 20(Year) to 50(Year) (—)
- Sex
- All
Inclusion Criteria
- •healthy adults between 20 and 50 years
- •volunteers who have plasma proportion of carboxyhemoglobin 3%
- •volunteers who have plasma proportion of methemoglobin 2%
- •volunteers who have total plasma hemoglobin concentration over 10 g/dL
Exclusion Criteria
- •History of respiratory diseases
- •History of cardiovascular disease
- •Smokers (including ex-smokers)
- •History of fainting
- •History of diabetes
- •Obesity (BMI> 30 kg/m2)
- •Allen’s test results, those who do not recover the color of their fingers and palms within 10 seconds
- •History of allergic reaction to lidocaine, a local anesthetic
Investigators
Similar Trials
Recruiting
Not Applicable
A Phase I/II exploratory clinical trial to evaluate the efficacy and safety of RBBM-S1 in patients requiring lumbar interbody fusion for degenerative lumbar disease, in comparison with the standard treatment of autologous bone grafting.lumbar stenosis, spondylolisthesis, spondylolysis, scoliosis, instability, disc diseasejRCT203125056936
Recruiting
Not Applicable
A Clinical Study in Adults to evalute the Accuracy and Safety of a Non-Invasive Chair-Based Device for Measuring Vital SignsCTRI/2026/02/104623Aarogya Tech, Inc110
Recruiting
Not Applicable
A clinical study to confirm the efficacy and safety of hard contact lenses for vision correction (SS-200)Corneal astigmatismjRCT203226029030
Recruiting
Phase 1
A phase 1b trial to study the safety and effect of ZP9830 in patients with plaque psoriasisPlaque Psoriasis2026-525220-15-00Zealand Pharma A/S32
Recruiting
Phase 1
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.2025-522243-17-00Philogen S.p.A.96
